EN
HI
Summary
As of 26 Sep, 2026, Senores Pharmaceuticals stock price is ₹1355.2. During the trading session, the stock has moved between an intraday low of ₹1336.30 and an intraday high of ₹1394.40. Over the last 52 weeks, Senores Pharmaceuticals has traded between ₹662.45 and ₹1599.00.
The stock has recorded a trading volume of 2,80,996 shares,. Its Average Traded Price (ATP) is ₹1365.14, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 20 @ ₹1355.20.
Senores Pharmaceuticals has an upper circuit limit of ₹1626.20 and a lower circuit limit of ₹1084.20. The total value traded stands at ₹38.36 CR, and the delivery percentage for the day is 51.11%.
The stock is currently traded with a market lot size of 1. Senores Pharmaceuticals also offers a dividend yield of 0%.
Senores Pharmaceuticals Share Price Chart
Senores Pharmaceuticals Share Key Metrics
Volume
2.81 L
Market Cap
6241.18 CR
LTQ@LTP
20@1355.20
ATP
1365.14
Var Margin
20.05 %
Circuit Range
1084.2-1626.2
Delivery %
51.11 %
Value
38.36 CR
ASM/GSM
No
Market Lot
1
Senores Pharmaceuticals Fundamentals
P/E Ratio
49.42
P/B Ratio
6.48
Div. Yield
0
Sector P/E
38.14
Sector P/B
3.67
Sec. Div. Yield
0.51
Senores Pharmaceuticals Resistance and Support
Pivot 1361.1
Resistance
First Resistance
1381.2
Second Resistance
1418.1
Third Resistance
1438.2
Support
First Support
1324.2
Second Support
1304.1
Third Support
1267.2
Senores Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 25 2026 | 1344.3 | 1355.2 | 0.81% | 1394.4 | 1336.3 |
| Thu Sep 24 2026 | 1384.5 | 1344.3 | -2.83% | 1398 | 1341 |
| Wed Sep 23 2026 | 1377.09 | 1383.4 | 0.25% | 1417.9 | 1377 |
Senores Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-27 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-01-20 | Quarterly Results & Others |
| 2026-01-07 | Others |
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
| 2025-01-23 | Quarterly Results & Others |
Senores Pharmaceuticals News
Senores Pharmaceuticals Ltd - 544319 - Successful Completion Of USFDA Inspection
Senores Pharma's subsidiary, Apnar Pharma Private Limited, successfully completed its USFDA inspection at its Vadodara manufacturing facility. The inspection, conducted from September 07-11, 2026, resulted in one minor procedural observation and no GMP-related observations, indicating operational compliance.
Sep 11 2026 13:42:44
Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Senores Pharmaceuticals will attend an Investor Conference hosted by Elara Capital on September 2, 2026. The meeting will involve both group and one-on-one interactions in Mumbai, discussing publicly available information.
Aug 27 2026 12:45:07
Senores Pharmaceuticals Management
| Name | Position |
|---|---|
| Vinay Kumar Mishra | Company Secretary & Compliance Officer |
| Swapnil Jatinbhai Shah | Managing Director |
Senores Pharmaceuticals Similar Stocks
Symbiotec Pharmalab Ltd.
1003.35
-20.70 (2.02%)
Kovai Medical Center & Hospital Ltd.
6090.50
-10.50 (0.17%)
Morepen Laboratories Ltd.
120.38
3.78 (3.24%)
Orchid Pharma Ltd.
1064.90
-31.25 (2.85%)
IOL Chemicals And Pharmaceuticals Ltd.
204.19
0.97 (0.48%)
FDC Ltd.
341.00
-4.70 (1.36%)
Artemis Medicare Services Ltd.
357.70
25.00 (7.51%)
Supriya Lifescience Ltd.
985.20
23.45 (2.44%)
RPG Life Sciences Ltd.
3050.60
150.70 (5.20%)
Senores Pharmaceuticals FAQs
The Buying Price of Senores Pharmaceuticals share is 1355.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Senores Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Senores Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Senores Pharmaceuticals shares is 49.42. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Senores Pharmaceuticals shares is 6.48. Useful to assess the stock's value relative to its book value.
To assess Senores Pharmaceuticals’s valuation compare Sector P/E, P/B which are 38.14 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Senores Pharmaceuticals is 6241.18 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Senores Pharmaceuticals share price is 1599.00 & 662.45. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Senores Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SENORES
Or Download Choice FinX App
Daily Research Calls
₹0 AMC for First Year
Dedicated RM Support
